214 related articles for article (PubMed ID: 22009181)
1. Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2.
Lee NO; Park JW; Lee JA; Shim JH; Kong SY; Kim KT; Lee YS
J Cancer Res Clin Oncol; 2012 Jan; 138(1):73-84. PubMed ID: 22009181
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma.
Park JW; Lee YS; Kim JS; Lee SK; Kim BH; Lee JA; Lee NO; Kim SH; Hong EK
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1973-83. PubMed ID: 25842034
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
Badiola I; Villacé P; Basaldua I; Olaso E
Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
Liu XH; Kirschenbaum A; Lu M; Yao S; Dosoretz A; Holland JF; Levine AC
J Biol Chem; 2002 Dec; 277(51):50081-6. PubMed ID: 12401798
[TBL] [Abstract][Full Text] [Related]
5. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
Shen Q; Cicinnati VR; Zhang X; Iacob S; Weber F; Sotiropoulos GC; Radtke A; Lu M; Paul A; Gerken G; Beckebaum S
Mol Cancer; 2010 Aug; 9():227. PubMed ID: 20799954
[TBL] [Abstract][Full Text] [Related]
7. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
8. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma.
von Marschall Z; Cramer T; Höcker M; Finkenzeller G; Wiedenmann B; Rosewicz S
Gut; 2001 Jan; 48(1):87-96. PubMed ID: 11115828
[TBL] [Abstract][Full Text] [Related]
9. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induces discoidin domain receptor-2 expression via the p38 pathway in vascular smooth muscle cells to increase their migration.
Chen SC; Wang BW; Wang DL; Shyu KG
Biochem Biophys Res Commun; 2008 Oct; 374(4):662-7. PubMed ID: 18664364
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
Sun YZ; Cai N; Liu NN
Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
[TBL] [Abstract][Full Text] [Related]
12. Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.
Jang ES; Yoon JH; Lee SH; Lee SM; Lee JH; Yu SJ; Kim YJ; Lee HS; Kim CY
J Cancer Res Clin Oncol; 2014 Jan; 140(1):133-44. PubMed ID: 24281334
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
[TBL] [Abstract][Full Text] [Related]
14. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
[TBL] [Abstract][Full Text] [Related]
15. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of interferon-alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice.
Cao B; Chen XP; Zhu P; Ding L; Guan J; Shi ZL
World J Gastroenterol; 2008 Nov; 14(44):6802-7. PubMed ID: 19058305
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.
Park JW; Park JE; Lee JA; Lee CW; Kim CM
J Cancer Res Clin Oncol; 2006 Mar; 132(3):184-92. PubMed ID: 16331492
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
[TBL] [Abstract][Full Text] [Related]
19. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
[TBL] [Abstract][Full Text] [Related]
20. [Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor].
Song IH; Kim DW; Shin KC; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Kim EY
Korean J Hepatol; 2008 Sep; 14(3):351-9. PubMed ID: 18815458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
